eCCF® Approved for DOT Drug Testing
To our valued clients and partners,
Today marks an exciting advancement for Alere and the drug testing industry, with the Department of Transportation (DOT) announcing its approval to use the electronic chain of custody form (eCCF) for regulated drug testing.
eCCF® was introduced to the industry more than 15 years ago through Alere eScreen®. We have maintained a long-standing goal to receive DOT approval for our eCCF solution and have worked diligently to drive adoption of this technology in more than 3,000 clinic locations across the United States in anticipation of its approval.
Although the approval has finally come, we still have work to do. We are coordinating with the National Laboratory Certification Program (NLCP) to ensure that they have the data required to complete their inspections of our laboratories in order to begin using eCCFs for DOT-regulated testing. As our laboratories receive their approvals, we will enable our eCCF for customers that utilize them.
Many more details related to implementation steps will follow. Alere is committed to bringing this long-awaited solution to our DOT customers and clinics as quickly as possible. Today, we are pleased to share with our clients the approval of this market-changing technology.
To all who have collaborated with us to reach this milestone, congratulations!
For more details:
- View the federal register at:
- View the DOT's PDF announcement at: